Us Bancorp \De\ Castle Biosciences Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Castle Biosciences Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 4,615 shares of CSTL stock, worth $127,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,615

Previous 232 1889.22%

Holding current value

$127,927

Previous $5,000 2520.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$17.4 - $31.47 $76,264 - $137,933	4,383 Added 1889.22%	4,615 $131,000
Q2 2024 Aug 06, 2024	SELL	$18.84 - $24.94 $4,408 - $5,835	-234 Reduced 50.21%	232 $5,000
Q1 2024 May 07, 2024	BUY	$18.06 - $25.3 $2,979 - $4,174	165 Added 54.82%	466 $10,000
Q4 2023 Feb 09, 2024	BUY	$12.19 - $22.43 $280 - $515	23 Added 8.27%	301 $6,000
Q3 2023 Nov 03, 2023	SELL	$13.28 - $20.3 $13 - $20	-1 Reduced 0.36%	278 $4,000
Q2 2023 Aug 09, 2023	BUY	$11.66 - $26.0 $466 - $1,040	40 Added 16.74%	279 $3,000
Q1 2023 May 09, 2023	BUY	$19.47 - $28.49 $369 - $541	19 Added 8.64%	239 $5,000
Q4 2022 Feb 13, 2023	SELL	$18.08 - $30.0 $60,803 - $100,890	-3,363 Reduced 93.86%	220 $5,000
Q3 2022 Oct 27, 2022	SELL	$22.51 - $34.32 $207,632 - $316,567	-9,224 Reduced 72.02%	3,583 $93,000
Q2 2022 Aug 01, 2022	SELL	$16.0 - $45.99 $58,576 - $168,369	-3,661 Reduced 22.23%	12,807 $281,000
Q1 2022 May 11, 2022	BUY	$33.17 - $46.98 $122,529 - $173,544	3,694 Added 28.92%	16,468 $739,000
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $31,872 - $55,145	-816 Reduced 6.0%	12,774 $547,000
Q3 2021 Nov 10, 2021	BUY	$60.13 - $77.6 $610,379 - $787,717	10,151 Added 295.17%	13,590 $904,000
Q2 2021 Aug 05, 2021	BUY	$50.07 - $76.78 $141,648 - $217,210	2,829 Added 463.77%	3,439 $252,000
Q1 2021 Apr 28, 2021	BUY	$58.92 - $97.33 $35,941 - $59,371	610 New	610 $42,000

Others Institutions Holding CSTL

# of Institutions

201

Shares Held

24.5M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $729M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account